Athyrium Capital Management LP 13D and 13G filings for Biora Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-27 4:22 pm Unchanged |
2021-08-24 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Capital Management LP | 184,170,513 47.000% |
0 (Unchanged) |
Filing |
| 2021-06-21 4:32 pm Purchase |
2021-06-01 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Capital Management LP | 184,170,513 64.200% |
43,656,118 (+31.07%) |
Filing |
| 2020-12-11 4:30 pm Purchase |
2020-12-07 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Capital Management LP | 140,514,395 67.100% |
82,256,030 (+141.19%) |
Filing |
| 2020-07-06 4:29 pm Purchase |
2020-06-23 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Capital Management LP | 58,258,365 49.800% |
58,258,365 (New Position) |
Filing |